Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;5(3):e000783.
doi: 10.1136/esmoopen-2020-000783.

Call for ensuring cancer care continuity during COVID-19 pandemic

Marco Tagliamento  1 , Matteo Lambertini  2 , Carlo Genova  3 , Emanuela Barisione  4 , Andrea De Maria  5 , Marco Grosso  4 , Francesca Poggio  3 , Stefano Vagge  6 , Francesco Boccardo  2 , Paolo Pronzato  3 , Lucia Del Mastro  7
Affiliations
Comment

Call for ensuring cancer care continuity during COVID-19 pandemic

Marco Tagliamento et al. ESMO Open. 2020 May.
No abstract available

Keywords: COVID-19; SARS-CoV-2; cancer; treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Marco Tagliamento declares travel, accommodation, expenses supported by Roche, Bristol-Myers Squibb, Astra Zeneca, Takeda, and activity as Medical Writer supported by Novartis outside the submitted work. Matteo Lambertini acted as consultant for Roche and Ely Lilly, and received speaker honoraria from Roche, Takeda and Theramex outside the submitted work. Carlo Genova received honoraria from Astra Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Roche outside the submitted work. Francesca Poggio declares travel, accommodations, expenses supported by Takeda, Ely Lilly, and received honoraria from Merck Sharp & Dohme, Ely Lilly, Novartis outside the submitted work. Lucia Del Mastro reports personal fees from Roche, Pfeizer, Ipsen, Eli Lilly, Novartis, Takeda, Merck Sharp & Dohme, Genomic Health, Seattle Genetics, and non-financial support from Celgene outside the submitted work. The other authors declare no competing interests.

Comment on

References

    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Liang W, Guan W, Chen R, et al. . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335–7. 10.1016/S1470-2045(20)30096-6 - DOI - PMC - PubMed
    1. Zhang L, Zhu F, Xie L, et al. . Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology 2020. 10.1016/j.annonc.2020.03.296 - DOI - PMC - PubMed
    1. Lambertini M, Toss A, Passaro A, et al. . Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO Open 2020;5:e000759 10.1136/esmoopen-2020-000759 - DOI - PMC - PubMed
    1. Bai Y, Yao L, Wei T, et al. . Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020;323:1406 10.1001/jama.2020.2565 - DOI - PMC - PubMed